- Home
- WHD vs IMVT Comparison
WHD vs IMVT Comparison
Compare WHD & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHD
- IMVT
- Stock Information
- Founded
- WHD 2011
- IMVT N/A
- Country
- WHD United States
- IMVT United States
- Employees
- WHD N/A
- IMVT N/A
- Industry
- WHD Metal Fabrications
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WHD Industrials
- IMVT Health Care
- Exchange
- WHD Nasdaq
- IMVT Nasdaq
- Market Cap
- WHD 2.7B
- IMVT 2.5B
- IPO Year
- WHD 2018
- IMVT N/A
- Fundamental
- Price
- WHD $41.03
- IMVT $14.30
- Analyst Decision
- WHD Hold
- IMVT Buy
- Analyst Count
- WHD 6
- IMVT 10
- Target Price
- WHD $52.33
- IMVT $40.14
- AVG Volume (30 Days)
- WHD 908.9K
- IMVT 1.5M
- Earning Date
- WHD 04-30-2025
- IMVT 05-28-2025
- Dividend Yield
- WHD 1.27%
- IMVT N/A
- EPS Growth
- WHD 11.86
- IMVT N/A
- EPS
- WHD 2.83
- IMVT N/A
- Revenue
- WHD $1,136,010,000.00
- IMVT N/A
- Revenue This Year
- WHD $1.34
- IMVT $108.88
- Revenue Next Year
- WHD $5.85
- IMVT N/A
- P/E Ratio
- WHD $14.48
- IMVT N/A
- Revenue Growth
- WHD N/A
- IMVT N/A
- 52 Week Low
- WHD $33.80
- IMVT $12.72
- 52 Week High
- WHD $70.01
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- WHD 52.34
- IMVT 41.40
- Support Level
- WHD $39.38
- IMVT $14.84
- Resistance Level
- WHD $40.83
- IMVT $16.44
- Average True Range (ATR)
- WHD 1.42
- IMVT 0.94
- MACD
- WHD 0.73
- IMVT 0.05
- Stochastic Oscillator
- WHD 97.06
- IMVT 30.52
About WHD Cactus Inc.
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).